Related Experiment Videos
Cortistatin as a potential multistep therapeutic agent for inflammatory disorders
Elena Gonzalez-Rey1, Mario Delgado
1Institute of Parasitology and Biomedicine, CSIC, Granada, Spain.
Drug News & Perspectives
|November 3, 2006
Summary
Cortistatin, a neuropeptide, shows promise in treating inflammatory and autoimmune diseases by restoring immune tolerance. It downregulates inflammation and promotes regulatory T cells, offering therapeutic benefits.
Area of Science:
- Immunology
- Endocrinology
- Pharmacology
Background:
- Immune tolerance is crucial for preventing autoimmunity and maintaining homeostasis.
- Identifying factors that restore immune tolerance is key for treating inflammatory and autoimmune diseases.
- Cortistatin, a cyclic neuropeptide, is produced by and binds to immune cells, suggesting an anti-inflammatory role.
Purpose of the Study:
- To review recent studies on cortistatin's therapeutic potential in inflammatory and autoimmune conditions.
- To evaluate cortistatin's effects on inflammatory responses and immune tolerance.
Main Methods:
- Review of experimental models for sepsis, rheumatoid arthritis, and inflammatory bowel disease.
- Analysis of cortistatin's impact on inflammatory markers and immune cell populations, including regulatory T cells (Treg).
Main Results:
- Cortistatin treatment demonstrated clinical and pathological benefits in experimental models.
- Cortistatin effectively downregulated inflammatory responses and Th1-mediated autoimmune components.
- Treatment promoted the emergence of regulatory T cells (Treg) that suppress autoreactive T cells.
Conclusions:
- Cortistatin shows significant promise as a therapeutic agent for chronic inflammatory and autoimmune diseases.
- Its ability to restore immune tolerance through anti-inflammatory mechanisms and Treg induction is a key finding.
- Further research is needed, but cortistatin represents an exciting candidate for novel treatments.
Related Concept Videos
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...